Lilly Grows AI Footprint with Up-to-$2.75B Insilico Collaboration

Monday, March 30, 2026Fay Lin, PhDView original

Lilly has agreed to pay Insilico $115 million upfront, as well as development, regulatory, and commercial milestones. Insilico will grant the pharma giant an exclusive global license to develop, manufacture, and commercialize “potentially best-in-class, novel oral therapeutics."

The post Lilly Grows AI Footprint with Up-to-$2.75B Insilico Collaboration appeared first on GEN - Genetic Engineering and Biotechnology News.